Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Local Government Drug Testing Amendments
Number
H.B. 246 (2026GS)
Sponsor
Rep. Maloy, A. Cory
Final action
Governor Signed 3/17/2026
Outcome
Became law — signed by Gov. Spencer J. Cox

Summary

This bill amends government entity drug testing provisions.

What it does

  • This bill:
  • modifies the definition of "sample" to include oral fluid;
  • clarifies the type of sample that a local governmental entity or state institution of higher education may require that a donor submit for drug testing; and
  • requires that sample collection be performed in accordance with instructions prepared by an independent entity.

Every vote on this bill

2026-02-03House Comm - Favorable Recommendation
House Political Subdivisions Committee
7-0-5not eligible / no record
2026-02-03House Comm - Consent Calendar Recommendation
House Political Subdivisions Committee
7-0-5not eligible / no record
2026-02-19Senate Comm - Favorable Recommendation
Senate Education Committee
5-0-2not eligible / no record
2026-02-19Senate Comm - Consent Calendar Recommendation
Senate Education Committee
5-0-2not eligible / no record
2026-02-25Senate/ passed 3rd reading
Senate President
27-0-2not eligible / no record
2026-02-06House/ passed 3rd reading
Senate Secretary
69-0-6YEA

Bill text

enrolled version · official source
14
34-41-101
34-41-103
34-41-104
0
Local Government Drug Testing Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: A. Cory Maloy
Senate Sponsor: Heidi Balderree
LONG TITLE
General Description:
This bill amends government entity drug testing provisions. 
Highlighted Provisions:
This bill:
modifies the definition of "sample" to include oral fluid;
clarifies the type of sample that a local governmental entity or state institution of higher 
education may require that a donor submit for drug testing; and
requires that sample collection be performed in accordance with instructions prepared by 
an independent entity.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
34-41-101
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
34-41-103
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
34-41-104
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
34-41-101
 is amended to read:
34-41-101
. Definitions.
As used in this chapter:
(1)
"Donor" means an employee, a volunteer, a prospective employee, or a prospective 
volunteer of a local government entity or an institution of higher education.
(2)
"Drug" means any substance recognized as a drug in the United States Pharmacopeia, 
the National Formulary, the Homeopathic 
Pharmacopeia
Pharmacopoeia
, or other drug 
compendia, including Title 
58, Chapter 37
, Utah Controlled Substances Act, or 
supplement to any of those compendia.
(3)
"Drug testing" means the scientific analysis for the presence of drugs or their 
metabolites in the human body in accordance with the definitions and terms of this 
chapter.
(4)
"Institution of higher education" means the same as that term is defined in Section 
53H-1-101
.
(5)
"Local governmental employee" means any person or officer in the service of a local 
governmental entity or institution of higher education for compensation.
(6)
(a)
"Local governmental entity" means any political subdivision of Utah including 
any county, municipality, local school district, special district, special service district, 
or any administrative subdivision of those entities.
(b)
"Local governmental entity" does not mean Utah state government or its 
administrative subdivisions provided for in Sections 
63A-17-1001
 through 
63A-17-1006
.
(7)
"Periodic testing" means preselected and preannounced drug testing of employees or 
volunteers conducted on a regular schedule.
(8)
"Prospective employee" means any person who has made a written or oral application to 
become an employee of a local governmental entity or an institution of higher education.
(9)
"Random testing" means the unannounced drug testing of an employee or volunteer 
who was selected for testing by using a method uninfluenced by any personal 
characteristics other than job category.
(10)
"Reasonable suspicion for drug testing" means an articulated belief based on the 
recorded specific facts and reasonable inferences drawn from those facts that a local 
government employee or volunteer is in violation of the drug-free workplace policy.
(11)
"Rehabilitation testing" means unannounced but preselected drug testing done as part 
of a program of counseling, education, and treatment of an employee or volunteer in 
conjunction with the drug-free workplace policy.
(12)
"Safety sensitive position" means any local governmental or institution of higher 
education position involving duties which directly affects the safety of governmental 
employees, the general public, or positions where there is access to controlled 
substances, as defined in Title 
58, Chapter 37
, Utah Controlled Substances Act, during 
the course of performing job duties.
(13)
"Sample" means urine, blood, breath, 
saliva
oral fluid
, or hair.
(14)
"Volunteer" means any person who donates services as authorized by the local 
governmental entity or institution of higher education without pay or other 
compensation except expenses actually and reasonably incurred.
Section 2. Section 
34-41-103
 is amended to read:
34-41-103
. Policy requirements.
(1)
(a)
A local governmental entity or institution of higher education may not test a donor 
for the presence of drugs, unless the local government entity or institution of higher 
education:
(i)
adopts a written policy or ordinance for the testing;
(ii)
distributes the policy or ordinance to employees and volunteers; and
(iii)
makes the policy or ordinance available for review by prospective employees 
and prospective volunteers.
(b)
The local governmental entity or institution of higher education may only test or 
retest for the presence of drugs in accordance with the policy or ordinance described 
in Subsection 
(1)(a)
.
(2)
The local government entity or institution of higher education:
(a)
shall collect and test samples in accordance with Section 
34-41-104
; and
(b)
if otherwise permitted by law, is not limited only to collecting or testing in 
circumstances where there are indications of job-related impairment of an employee 
or volunteer.
(3)
The use and disposition of all drug test results are subject to the limitations of Title 
63G, 
Chapter 2
, Government Records Access and Management Act, and the Americans with 
Disabilities Act of 1990, 42 U.S.C. 12101 through 12213.
(4)
A donor who is subject to testing under a policy or ordinance described in Subsection 
(1)(a)
 shall:
(a)
submit 
an oral
a blood, breath, oral fluid, or hair
 sample for testing; or
(b)
submit a split urine sample for testing or retesting.
(5)
Unless the policy or ordinance described in Subsection 
(1)(a)
 provides otherwise, the 
local governmental entity or institution of higher education may specify the type of 
sample, described in Subsection 
(4)
, that the donor is required to submit.
(6)
A split urine sample shall consist of at least 45 milliliters of urine, divided into two 
specimen bottles with:
(a)
at least 30 milliliters of urine in one bottle, for the initial test; and
(b)
at least 15 milliliters of urine in the other bottle for retesting, if requested under 
Subsection 
(7)
.
(7)
If the test results of a 
urine or oral
sample
 test indicate the presence of drugs, the local 
governmental entity or institution of higher education shall:
(a)
give notice to the donor:
(i)
of the test results; and
(ii)
for a urine test, that the donor may, within 72 hours after the local government 
entity or institution of higher education provides the notice, request testing of the 
second sample; and
(b)
test the second sample if the donor timely requests testing of the second sample.
(8)
The expense of testing the second urine sample will be equally divided between the 
donor and the local governmental entity or institution of higher education.
(9)
The test results of the samples shall be considered at any subsequent disciplinary 
hearing if the requirements of this section and Section 
34-41-104
 are complied with in 
the collection, handling, and testing of the samples.
Section 3. Section 
34-41-104
 is amended to read:
34-41-104
. Requirements for identification, collection, and testing of samples.
(1)
The local governmental entity or institution of higher education shall ensure that:
(a)
all sample collection under this chapter is performed
 in accordance with instructions 
prepared
 by an entity independent of the local government or institution of higher 
education;
(b)
all testing for drugs under this chapter is performed by an independent laboratory 
certified for employment drug testing by either the Substance Abuse and Mental 
Health Services Administration or the College of American 
Pathology
Pathologists
;
(c)
the instructions, chain of custody forms, and collection kits, including containers and 
seals, used for sample collection are prepared by an independent laboratory certified 
for employment drug testing by either the Substance Abuse and Mental Health 
Services Administration or the College of American 
Pathology
Pathologists
; and
(d)
sample collection and testing for drugs under this chapter is in accordance with the 
requirements of this section.
(2)
The local governmental entity or institution of higher education may:
(a)
in accordance with a policy or ordinance described in Subsection 
34-41-103(1)(a)
, 
require samples from a donor;
(b)
require presentation of reliable identification to the person collecting the samples; and
(c)
in order to dependably test for the presence of drugs, designate the type of sample to 
be used for testing.
(3)
The local governmental entity or institution of higher education shall ensure that the 
local governmental entity's or institution of higher education's ordinance or policy 
requires that:
(a)
the collection of samples is performed under reasonable and sanitary conditions;
(b)
samples are collected and tested:
(i)
to ensure the privacy of the individual being tested; and
(ii)
in a manner reasonably calculated to prevent substitutions or interference with the 
collection or testing of reliable samples;
(c)
sample collection is appropriately documented to ensure that:
(i)
samples are labeled and sealed to reasonably preclude the probability of 
erroneous identification of test results; and
(ii)
a donor has the opportunity to provide notification of any information:
(A)
that a donor considers relevant to the test, including identification of currently 
or recently used prescription or nonprescription drugs or other relevant medical 
information; and
(B)
in compliance with the Americans with Disabilities Act of 1990, 42 U.S.C. 
12101 through 12213;
(d)
sample collection, storage, and transportation to the place of testing are performed in 
a manner that reasonably precludes the probability of sample misidentification, 
contamination, or adulteration; and
(e)
sample testing conforms to scientifically accepted analytical methods and procedures.
(4)
Before the result of any test may be used as a basis for any action by a local 
governmental entity or institution of higher education under Section 
34-41-105
, the local 
governmental entity or institution of higher education shall:
(a)
verify or confirm any positive initial screening test by gas chromatography, gas 
chromatography-mass spectroscopy, or other comparably reliable analytical methods; 
and 
(b)
provide the notice described in Subsection 
34-41-103(7)
, as soon as possible after a 
positive test result, at the last known address or telephone number of the donor.
(5)
Any drug testing 
Except for drug testing of a prospective employee or a prospective 
volunteer, drug testing 
by a local governmental entity or institution of higher education 
shall occur during or immediately after the regular work period of the employee or 
volunteer and shall be considered as work time for purposes of compensation and 
benefits.
(6)
The local governmental entity or institution of higher education shall pay
:
(a)
all costs of sample collection and initial testing for drugs required under the policy 
or ordinance described in Subsection 
34-41-103(1)(a)
,
; and
(b)
 including the costs of transportation if the testing of an
if the donor is a current
employee or 
current 
volunteer 
and testing 
is conducted at a place other than the 
workplace
, the cost of transportation to the testing location
.
Section 4. 
Effective Date.
This bill takes effect on 
May 6, 2026
.
2-27-26 8:42 AM